SCHEMBL24810838

SCHEMBL24810838

c1ccc2c(c1)oc1ccc(-c3ccc(-c4ccc(-n5c6ccccc6c6ccccc65)c(-c5ccc6oc7ccccc7c6c5)c4)cc3)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ PLA2G2A P14555 5/20 0.39
▸ PLA2G4A P47712 5/20 0.39
▸ AHR P35869 2/20 0.37
▸ HSP90AA1 P07900 1/20 0.37
▸ HSP90AB1 P08238 1/20 0.37
▸ ALOX5 P09917 1/20 0.36
▸ CASP3 P42574 1/20 0.35
▸ SENP7 Q9BQF6 1/20 0.35
▸ SENP6 Q9GZR1 1/20 0.35
▸ CHEK2 O96017 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24810836 0.95 PLA2G2A (0.43) MAPTSMN1; SMN2NPC1KDM4EMEN1
SCHEMBL17689865 0.91 PLA2G2A (0.40) MAPTSMN1; SMN2NPC1KDM4EMEN1
SCHEMBL24811868 0.89 KDM4E (0.41) MAPTSMN1; SMN2NPC1KDM4EMEN1
SCHEMBL21443966 0.88 KMT2A (0.55) MAPTSMN1; SMN2NPC1KDM4EMEN1
SCHEMBL26813288 0.87 ALDH1A1 (0.41) MAPTSMN1; SMN2NPC1KDM4EMEN1
SCHEMBL21147306 0.87 PLA2G2A (0.36) MAPTSMN1; SMN2NPC1KDM4EMEN1
SCHEMBL21147287 0.86 PLA2G2A (0.36) MAPTSMN1; SMN2NPC1KDM4EMEN1
SCHEMBL25945734 0.85 CHEK2 (0.37) MAPTSMN1; SMN2NPC1KDM4EMEN1
SCHEMBL24810839 0.85 MAOA (0.40) MAPTSMN1; SMN2NPC1KDM4EMEN1
SCHEMBL18523656 0.85 SMN1; SMN2 (0.35) MAPTSMN1; SMN2NPC1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 MAPT 1926/4885SMN1; SMN2 3245/4885NPC1 469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback